PALISADE BIO, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Palisade Bio, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Palisade Bio, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 966K shares, a 85.9% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 966K -5.88M -85.9% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 851K -3.71M -81.3% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 618K -2.33M -79% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 9.21M -67.9M -88.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 6.85M -15M -68.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 4.56M -13.7M -75% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 2.94M +2.66M +934% Dec 31, 2022 10-K 2024-03-26
Q3 2022 77.1M +64.2M +496% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 21.9M +10.5M +92% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 18.2M +15.4M +533% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 285K -2.49M -89.7% Dec 31, 2021 10-K 2023-03-22
Q3 2021 12.9M -4.37M -25.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 11.4M -5.9M -34.1% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 2.88M -6.55M -69.4% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 2.77M -1.09M -28.2% Dec 31, 2020 10-K 2022-03-17
Q3 2020 17.3M +14.5M +514% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 17.3M +16.3M +1626% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 9.43M -8.78M -48.2% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 3.87M +2.96M +325% Dec 31, 2019 10-K 2021-03-22
Q3 2019 2.82M -12.4M -81.5% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 1M -14.2M -93.4% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 18.2M +3.05M +20.1% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 910K -14.2M -94% Dec 31, 2018 10-K 2020-03-27
Q3 2018 15.2M +59K +0.39% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 15.2M +3.15M +26.2% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 15.2M +3.42M +29.1% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 15.2M +4.13M +37.4% Dec 31, 2017 10-K 2019-03-22
Q3 2017 15.1M -99.7M -86.8% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 12M -103M -89.5% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 11.7M -80.3M -87.2% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 11M +3.96M +55.9% Dec 31, 2016 10-K 2018-04-02
Q3 2016 115M +23M +25.1% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 115M +24.4M +27% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 92M +1.71M +1.89% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 7.08M -80.7M -91.9% Dec 31, 2015 10-K 2017-03-23
Q3 2015 91.8M +4.63M +5.31% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 90.4M +3.52M +4.06% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 90.3M +3.65M +4.21% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 87.8M +9.9M +12.7% Dec 31, 2014 10-K 2016-03-14
Q3 2014 87.2M +10.5M +13.7% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 86.8M +16.2M +23% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 86.7M +17.9M +26% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 77.9M +9.7M +14.2% Dec 31, 2013 10-K 2015-03-16
Q3 2013 76.7M +8.7M +12.8% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 70.6M +16.5M +30.5% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 68.8M +14.7M +27.3% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 68.2M +19.5M +40.1% Dec 31, 2012 10-K 2014-03-10
Q3 2012 68M +19.3M +39.6% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 54.1M +5.61M +11.6% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 54.1M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 48.7M +1.78M +3.81% Dec 31, 2011 10-K 2013-03-15
Q3 2011 48.7M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 48.5M Jun 30, 2011 10-Q/A 2011-09-23
Q4 2010 46.9M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.